Subacute, silent embolization of amplatzer atrial septal defect closure device to the pulmonary artery.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3542515)

Published in J Cardiovasc Ultrasound on December 31, 2012

Authors

Jang-Won Son1, Jong-Seon Park

Author Affiliations

1: Division of Cardiology, Severance Cardiovascular Hospital, Seoul, Korea.

Articles cited by this

Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol (2002) 6.01

Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol (2002) 5.41

Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv (2004) 3.13

Nonoperative closure of atrial septal defects. Surgery (1974) 1.75

Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol (2008) 1.69

Percutaneous rescue of left ventricular embolized amplatzer septal occluder device. Catheter Cardiovasc Interv (2008) 1.17

Amplatzer septal occluder closure of atrial septal defect: evaluation of transthoracic echocardiography, cardiac CT, and transesophageal echocardiography. AJR Am J Roentgenol (2009) 1.17

The 'aortic rim' recount: embolization of interatrial septal occluder into the main pulmonary artery bifurcation after atrial septal defect closure. Interact Cardiovasc Thorac Surg (2007) 1.08

Supplementing transesophageal echocardiography with transthoracic echocardiography for monitoring transcatheter closure of atrial septal defects with attenuated anterior rim: a case series. Anesth Analg (2003) 0.90

Torn atrial septum during transcatheter closure of atrial septal defect visualized by real-time three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr (2010) 0.89

[Clinical efficacy and safety of the percutaneous treatment of secundum atrial septal defect with the Amplatzer occluder]. Arq Bras Cardiol (2004) 0.87

Articles by these authors

Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61

Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation (2013) 3.49

Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50

Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J (2010) 2.09

Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation (2005) 1.93

Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation (2004) 1.86

Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry. Am Heart J (2011) 1.82

The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation. Int J Cardiol (2007) 1.73

Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry). Am J Cardiol (2008) 1.61

Increased Variability of the Coupling Interval of Premature Ventricular Contractions as a Predictor of Cardiac Mortality in Patients With Left Ventricular Dysfunction. Circ J (2015) 1.41

Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol (2007) 1.32

Unusual left ventricular endocardial metastasis from primary lung cancer. J Cardiovasc Ultrasound (2012) 0.98

Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem (2004) 0.98

Neural tracts injuries in patients with hypoxic ischemic brain injury: diffusion tensor imaging study. Neurosci Lett (2012) 0.95

Homing of adipose-derived stem cells to radiofrequency catheter ablated canine atrium and differentiation into cardiomyocyte-like cells. Int J Cardiol (2009) 0.92

Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J (2008) 0.90

Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial. Circ Cardiovasc Interv (2012) 0.88

Aneurysm of sinus of valsalva dissecting into the interventricular septum after aortic valve replacement: diagnosis by echocardiography and magnetic resonance imaging and treatment with surgical sealant. Korean Circ J (2011) 0.88

Comparison of 5-year clinical outcomes between sirolimus-versus paclitaxel-eluting stent: Korean multicenter network analysis of 9000-patient cohort. Circ Cardiovasc Interv (2012) 0.86

A case of extrinsic compression of the left main coronary artery secondary to pulmonary artery dilatation. J Korean Med Sci (2013) 0.86

Acute myocardial infarction as a consequence of stent fracture and plaque rupture after sirolimus-eluting stent implantation. Int J Cardiol (2008) 0.86

High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting. Int J Cardiol (2012) 0.84

Characterization of the left atrial vortex flow by two-dimensional transesophageal contrast echocardiography using particle image velocimetry. Ultrasound Med Biol (2012) 0.83

Left ventricular noncompaction with a single coronary artery of anomalous origin. Int J Cardiol (2007) 0.81

Stent fracture and restenosis after zotarolimus-eluting stent implantation. Int J Cardiol (2009) 0.81

Two-year clinical outcomes after large coronary stent (4.0 mm) placement: comparison of bare-metal stent versus drug-eluting stent. Clin Cardiol (2010) 0.80

Outcomes according to presentation with versus without cardiogenic shock in patients with left main coronary artery stenosis and acute myocardial infarction. Am J Cardiol (2012) 0.79

Changes in smoking behavior and adherence to preventive guidelines among smokers after a heart attack. J Geriatr Cardiol (2013) 0.79

Clinical and angiographic outcomes of drug-eluting stents in patients with large vessel and single coronary artery lesion. Clin Cardiol (2010) 0.79

Comparison of long-term outcomes following sirolimus-eluting stent vs paclitaxel-eluting stent implantation in patients with long calcified coronary lesions. Clin Cardiol (2009) 0.79

Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients. Korean J Intern Med (2011) 0.78

Long-term clinical outcomes after angiographically defined very late stent thrombosis of drug-eluting stent. Clin Cardiol (2009) 0.78

RGS2 is a negative regulator of STAT3-mediated Nox1 expression. Cell Signal (2011) 0.77

The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial. Trials (2011) 0.77

Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: the comparison of efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial. Am Heart J (2013) 0.76

Seven-year clinical outcomes of sirolimus-eluting stent versus bare-metal stent: a matched analysis from a real world, single center registry. J Korean Med Sci (2013) 0.76

Efficacies of the new paclitaxel-eluting Coroflex Please stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please and Taxus (ECO-PLEASANT) trial: study rationale and design. Trials (2009) 0.75

Prevalence of extracardiac findings in the evaluation of ischemic heart disease by multidetector computed tomography. J Geriatr Cardiol (2013) 0.75

A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study. J Korean Med Sci (2013) 0.75

Therapeutic strategy for in-stent restenosis based on the restenosis pattern after drug-eluting stent implantation. Korean Circ J (2009) 0.75

Prognostic value of real time dobutamine stress myocardial contrast echocardiography in patients with chest pain syndrome. Int J Cardiovasc Imaging (2011) 0.75

Two-year clinical outcomes of patients with long segments drug-eluting stents: comparison of sirolimus-eluting stent with paclitaxel-eluting stent. J Korean Med Sci (2011) 0.75

Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents. Korean J Intern Med (2012) 0.75

Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization: Analysis of the prospective registry of DIAMOND (DIabetic acute myocardial infarctiON Disease) in Korea: an observational registry study. Medicine (Baltimore) (2016) 0.75

Multiple fistula and abnormal vascular plexus. Heart Asia (2010) 0.75

Long-Term Clinical Outcomes of True and Non-True Bifurcation Lesions According to Medina Classification- Results From the COBIS (COronary BIfurcation Stent) II Registry. Circ J (2015) 0.75

Two-year outcomes of the sirolimus-eluting stent according to unprotected left main lesion. Clin Cardiol (2009) 0.75

Comparison of the first- and second-generation limus-eluting stents for bifurcation lesions from a Korean multicenter registry. Circ J (2015) 0.75

Breakdown of the intermediate-term fractal scaling exponent in sinus node dysfunction. New method for non-invasive evaluation of sinus node function. Circ J (2011) 0.75

Late-acquired incomplete stent apposition after everolimus-eluting stent versus sirolimus-eluting stent implantation in patients with non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction. EuroIntervention (2016) 0.75

Clinical usefulness of myocardial contrast echocardiography to detect stress-induced cardiomyopathy in the emergency department. Circ J (2012) 0.75

Clinical impact of Q-wave presence on electrocardiogram at presentation of patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention. Int Heart J (2014) 0.75

Impact of non-compliant balloons on long-term clinical outcomes in coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II registry. EuroIntervention (2016) 0.75

Initial Total Bilirubin and Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Drug-Eluting Stents. Circ J (2016) 0.75